首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1435708

2024 年生物分析測試服務全球市場報告

Bioanalytical Testing Services Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

生物分析測試服務的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 9.5% 的複合年成長率 (CAGR) 成長至 49.9 億美元。預測期內的預期成長將由生物製藥管道的擴大、生物相似藥的開發增加、精準醫學的進步以及臨床試驗複雜性的增加所推動。這段時期的主要趨勢包括人工智慧（AI）的整合、綜合藥物趨勢分析、微生物組分析服務、高通量技術的採用和生物樣本分析。

旨在控制感染疾病爆發的政府舉措的擴大在推動生物分析測試服務市場的擴張方面發揮關鍵作用。冠狀病毒感染疾病（COVID-19）大流行的爆發對生物分析檢測服務提出了特別的需求，世界各國正在採取積極措施防止該疾病的傳播並減少其影響。我們敦促採取行動並增加支出。一個明顯的例子是 2021 年 3 月美國衛生與公眾服務部的公告，詳細說明了美國救援計畫投資 100 億美元，以加強篩檢測試，以安全地重新開放學校。此外，還撥款 22.5 億美元用於擴大對服務不足人口的檢測。對政府措施的財政承諾的增強預計將大大促進生物分析測試服務市場的持續成長。

慢性病的日益普及預計將在不久的將來推動生物分析測試服務市場的成長。慢性病的特徵是病情持續超過 3 個月，並且會隨著時間的推移而惡化，因此需要有效的診斷和監測工具。生物分析測試服務在識別和測量與慢性病相關的特定生物標記方面發揮關鍵作用，並協助監測治療藥物以確保治療範圍內的最佳藥物水平。例如，國家醫學圖書館 2023 年 1 月報告稱，美國50 歲及以上患有至少一種慢性疾病的人數預計將增加 99.5%，到 2050 年將達到 1.4266 億。是。世界衛生組織2022年9月發布的2022年重點報告顯示，全球每年有4,100萬人死亡，其中74%可歸因於非傳染性疾病（NCD）或慢性病。慢性病盛行率的快速增加是推動生物分析測試服務市場成長的關鍵驅動力。

全球生物分析測試服務市場，按測試類型、性能和預測細分，2018-2023、2023-2028、2033
ADME（吸收、分佈、代謝、排泄）
藥物動力學
動態
生物等效性
生物有效性
全球生物分析測試服務市場，按分子類型、表現和預測細分，2018-2023、2023-2028、2033
低分子
高分子
全球生物分析測試服務市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
製藥和生物製藥公司
合約開發/製造組織
受託研究機構

第 7 章區域與國家分析

全球生物分析測試服務市場，按地區、實際和預測，2018-2023、2023-2028、2033
全球生物分析測試服務市場，按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭格局及公司概況

生物分析檢測服務市場競爭格局
生物分析測試服務市場公司概況
- CD BioSciences
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Laboratory Corporation of America Holdings（LabCorp）
- Eurofins Scientific SE

第31章其他大型創新公司

ICON plc
PPD Inc.
SGS SA
WuXi AppTec
Syneos Health Inc.
STERIS plc
Sartorius AG
Charles River Laboratories Inc.
Intertek Group
Covance Inc.
PAREXEL International Corporation
Element Materials Technology
ALS Limited
Medpace Holdings Inc.
Almac Group

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r15418

Bioanalytical testing services encompass cutting-edge methodologies for quantifying analytes. These services play a pivotal role in identifying and characterizing pharmaceuticals and metabolites within biological fluids such as blood, plasma, serum, urine, or tissue extracts.

Bioanalytical testing services encompass various essential tests, including ADME (absorption, distribution, metabolism, and excretion), pharmacokinetic, pharmacodynamic, bioequivalence, and bioavailability assessments. ADME examines how a chemical undergoes absorption, distribution, metabolism, and excretion within a living organism, crucial for understanding drug processing. It aids in evaluating safety, toxicity, and the viability of drugs, offering precise targets for future research and development endeavors. These testing services analyze both small and large molecules, catering to pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, as well as contract research organizations. They serve as indispensable tools in drug development and assessment, providing vital insights into a compound's behavior within biological systems.

The bioanalytical testing services market research report is one of a series of new reports from The Business Research Company that provides bioanalytical testing services market statistics, including bioanalytical testing services industry global market size, regional shares, competitors with a bioanalytical testing services market share, detailed bioanalytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the bioanalytical testing services industry. This bioanalytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioanalytical testing services market size has grown strongly in recent years. It will grow from $3.23 billion in 2023 to $3.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. Historical growth can be attributed to the globalization of clinical studies, emphasis on pharmacokinetics, implementation of quality control measures, and the increasing focus on personalized medicine.

The bioanalytical testing services market size is expected to see strong growth in the next few years. It will grow to $4.99 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. Anticipated growth in the forecast period is fueled by the expansion of the biopharmaceutical pipeline, increased development of biosimilars, advancements in precision medicine, and the growing complexity of clinical trials. Key trends expected in this period involve the integration of artificial intelligence (AI), comprehensive pharmacokinetic analysis, services for microbiome analysis, adoption of high-throughput technologies, and biological sample analysis.

The growing government initiatives aimed at controlling infectious disease outbreaks are playing a significant role in propelling the expansion of the bioanalytical testing services market. The onset of the COVID-19 pandemic has particularly heightened the demand for bioanalytical testing services, prompting countries worldwide to take proactive measures and increase expenditures to prevent the spread and mitigate the impact of diseases. An illustrative example is the U.S. Department of Health and Human Services' announcement in March 2021, detailing an investment of $10 billion from the American Rescue Plan to bolster screening testing for the safe reopening of schools. Additionally, $2.25 billion was allocated to scale up testing in underserved populations. This increased financial commitment to government initiatives is expected to significantly contribute to the continued growth of the bioanalytical testing services market.

The escalating prevalence of chronic diseases is anticipated to drive the growth of the bioanalytical testing services market in the foreseeable future. Chronic diseases, characterized by enduring illness lasting three months or more and with the potential to worsen over time, necessitate effective diagnostic and monitoring tools. Bioanalytical testing services play a crucial role in identifying and measuring specific biomarkers associated with chronic diseases, aiding in therapeutic drug monitoring to ensure optimal drug levels within the therapeutic range. As an example, the National Library of Medicine reported in January 2023 that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050. Furthermore, according to the World Health Organization's 2022 Highlights in September 2022, 74% of all global deaths, amounting to 41 million annually, result from noncommunicable diseases (NCDs) or chronic diseases. This surge in chronic diseases' prevalence is a key driver propelling the growth of the bioanalytical testing services market.

Major companies within the bioanalytical testing services market are actively pursuing advanced solutions, exemplified by the introduction of technologies such as reverse transcription PCR (RT-PCR) tests, to fortify their market positions. RT-PCR is a laboratory technique involving the conversion of RNA into complementary DNA (cDNA) using the reverse transcriptase enzyme. A case in point is Eurofins Scientific SE, a France-based testing laboratory company, which, in June 2023, launched the NovaType SARS-CoV-2 RT-PCR assay. This clinically validated assay offers a short turnaround time, making it well-suited for the re-testing of millions of positive samples to identify specific virus variants. The NovaType SARS-CoV-2 RT-PCR assay, functioning in real-time, is designed for the qualitative detection of SARS-CoV-2, the virus responsible for COVID-19, and the subsequent identification of specific variants, including B.1.1.7 and B.1.351. This strategic focus on advanced solutions underscores the commitment of major companies to staying at the forefront of technological advancements in the bioanalytical testing services market.

Major companies in the bioanalytical testing services market are strategically investing in the development of advanced testing facilities as part of their efforts to sustain and enhance their market positions. Testing facilities, specialized environments equipped for conducting diverse tests on products, materials, systems, or components, play a pivotal role in ensuring accurate and reliable results. In October 2021, Thermo Fisher Scientific Inc., a prominent US-based biotechnology company, exemplified this strategic focus by launching a State-of-the-Art Bioanalytical Lab. This specialized facility is dedicated to bioanalytical services, involving the analysis of biological samples such as blood or tissue to detect and quantify drugs, metabolites, biomarkers, and other molecules. The lab is equipped with cutting-edge technologies, including liquid chromatography-mass spectrometry (LC-MS), which enables highly sensitive and specific analysis of drugs and other molecules. This emphasis on developing state-of-the-art testing facilities underscores the commitment of major companies to delivering high-quality bioanalytical testing services and maintaining a competitive edge in the market.

In February 2022, Eurofins Scientific, a France-based laboratory service company, announced the acquisition of Genetic Testing Service JSC for an undisclosed amount. This strategic move is expected to facilitate Eurofins' expansion in the clinical genetic testing market and complement its global network of clinical diagnostics laboratories. Genetic Testing Service JSC, based in Vietnam, is a company specializing in genetic testing services, including specialized DNA testing, genealogical DNA tests, and testing for conditions such as cancer and COVID-19.

Major companies operating in the bioanalytical testing services market report are CD BioSciences, Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, ICON PLC, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., STERIS PLC, Sartorius AG, Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Element Materials Technology, ALS Limited, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc., Cinven Ltd. (LGC Limited), Toxikon Inc., Absorption Systems LLC, Lotus Labs Pvt. Ltd., Bioneeds India Private Limited, Vipragen Biosciences Pvt. Ltd., Source BioScience

North America was the largest region in the bioanalytical testing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioanalytical testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioanalytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioanalytical testing services market includes revenues earned by entities by providing services such as method development, high throughput sample analysis, method validation, and pharmacokinetic and toxicokinetic support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioanalytical Testing Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioanalytical testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioanalytical testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioanalytical testing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Test Type: ADME (Absorption, Distribution, Metabolism, And Excretion); Pharmacokinetic; Pharmacodynamic; Bioequivalence; Bioavailability
2) By Molecule Type: Small Molecules; Large Molecules
3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Development And Manufacturing Organizations; Contract Research Organizations
Companies Mentioned: CD BioSciences; Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (Labcorp); Eurofins Scientific SE
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Bioanalytical Testing Services Market Characteristics

3. Bioanalytical Testing Services Market Trends And Strategies

4. Bioanalytical Testing Services Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Bioanalytical Testing Services Market Size and Growth

5.1. Global Bioanalytical Testing Services Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Bioanalytical Testing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Bioanalytical Testing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioanalytical Testing Services Market Segmentation

6.1. Global Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
ADME (Absorption, Distribution, Metabolism, And Excretion)
Pharmacokinetic
Pharmacodynamic
Bioequivalence
Bioavailability
6.2. Global Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Small Molecules
Large Molecules
6.3. Global Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical And Biopharmaceutical Companies
Contract Development And Manufacturing Organizations
Contract Research Organizations

7. Bioanalytical Testing Services Market Regional And Country Analysis

7.1. Global Bioanalytical Testing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Bioanalytical Testing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioanalytical Testing Services Market

8.1. Asia-Pacific Bioanalytical Testing Services Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioanalytical Testing Services Market

9.1. China Bioanalytical Testing Services Market Overview
9.2. China Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioanalytical Testing Services Market

10.1. India Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioanalytical Testing Services Market

11.1. Japan Bioanalytical Testing Services Market Overview
11.2. Japan Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioanalytical Testing Services Market

12.1. Australia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioanalytical Testing Services Market

13.1. Indonesia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioanalytical Testing Services Market

14.1. South Korea Bioanalytical Testing Services Market Overview
14.2. South Korea Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioanalytical Testing Services Market

15.1. Western Europe Bioanalytical Testing Services Market Overview
15.2. Western Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioanalytical Testing Services Market

16.1. UK Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioanalytical Testing Services Market

17.1. Germany Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioanalytical Testing Services Market

18.1. France Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioanalytical Testing Services Market

19.1. Italy Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. 2. Italy Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioanalytical Testing Services Market

20.1. Spain Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioanalytical Testing Services Market

21.1. Eastern Europe Bioanalytical Testing Services Market Overview
21.2. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioanalytical Testing Services Market

22.1. Russia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioanalytical Testing Services Market

23.1. North America Bioanalytical Testing Services Market Overview
23.2. North America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioanalytical Testing Services Market

24.1. USA Bioanalytical Testing Services Market Overview
24.2. USA Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioanalytical Testing Services Market

25.1. Canada Bioanalytical Testing Services Market Overview
25.2. Canada Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioanalytical Testing Services Market

26.1. South America Bioanalytical Testing Services Market Overview
26.2. South America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioanalytical Testing Services Market

27.1. Brazil Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioanalytical Testing Services Market

28.1. Middle East Bioanalytical Testing Services Market Overview
28.2. Middle East Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioanalytical Testing Services Market

29.1. Africa Bioanalytical Testing Services Market Overview
29.2. Africa Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioanalytical Testing Services Market Competitive Landscape And Company Profiles

30.1. Bioanalytical Testing Services Market Competitive Landscape
30.2. Bioanalytical Testing Services Market Company Profiles
- 30.2.1. CD BioSciences
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck KGaA
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Laboratory Corporation of America Holdings (LabCorp)
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eurofins Scientific SE
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Bioanalytical Testing Services Market Other Major And Innovative Companies

31.1. ICON plc
31.2. PPD Inc.
31.3. SGS SA
31.4. WuXi AppTec
31.5. Syneos Health Inc.
31.6. STERIS plc
31.7. Sartorius AG
31.8. Charles River Laboratories Inc.
31.9. Intertek Group
31.10. Covance Inc.
31.11. PAREXEL International Corporation
31.12. Element Materials Technology
31.13. ALS Limited
31.14. Medpace Holdings Inc.
31.15. Almac Group

32. Global Bioanalytical Testing Services Market Competitive Benchmarking

33. Global Bioanalytical Testing Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioanalytical Testing Services Market

35. Bioanalytical Testing Services Market Future Outlook and Potential Analysis

35.1 Bioanalytical Testing Services Market In 2028 - Countries Offering Most New Opportunities
35.2 Bioanalytical Testing Services Market In 2028 - Segments Offering Most New Opportunities
35.3 Bioanalytical Testing Services Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies